Literature DB >> 25243650

Plumbagin Protects Against Spinal Cord Injury-induced Oxidative Stress and Inflammation in Wistar Rats through Nrf-2 Upregulation.

W Zhang1, L Cheng1, Y Hou1, M Si1, Y-P Zhao1, L Nie1.   

Abstract

BACKGROUND: Spinal cord injury causes post-traumatic degeneration through series of biochemical events. This study aims to evaluate the possible protective mechanism of Plumbagin against Spinal cord injury induced oxidative stress and inflammation. Plumbagin is a potent antioxidant and shows anti-carcinogenic, anti-inflammatory and analgesic activities. However, its exact molecular mechanism of action has yet to be explored.
METHODS: We tested the effects of Plumbagin on spinal cord injury induced ROS generation and lipid peroxidation content in wistar rats. Additionally, the expression of 2 important transcription factors NF-κB and Nrf-2 was investigated.
RESULTS: Plumbagin treatment significantly ameliorated oxidative stress through inhibition of ROS and lipid peroxidation with a concomitant increase in antioxidant status. Western blot analysis revealed enhanced nuclear levels of Nrf-2, while NF-κB expression was suppressed during Plumbagin administration. Enzyme linked immunosorbent assay for pro-inflammatory cytokines (TNF-α, IL-1β) showed a significant downregulation followed by Plumbagin treatment in spinal cord injury rats.
CONCLUSION: Taken together, the data suggests potential and novel role of Plumbagin in cytoprotection by modulating NF-κB and Nrf-2 levels against spinal cord injury. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25243650     DOI: 10.1055/s-0034-1389950

Source DB:  PubMed          Journal:  Drug Res (Stuttg)        ISSN: 2194-9379


  8 in total

1.  The attenuating effects of plumbagin on pro-inflammatory cytokine expression in LPS-activated BV-2 microglial cells.

Authors:  Samia S Messeha; Najla O Zarmouh; Patricia Mendonca; Malak G Kolta; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2017-09-20       Impact factor: 3.478

2.  Plumbagin, a vitamin K3 analogue ameliorate malaria pathogenesis by inhibiting oxidative stress and inflammation.

Authors:  Amit Chand Gupta; Shilpa Mohanty; Archana Saxena; Anil Kumar Maurya; Dnyaneshwar U Bawankule
Journal:  Inflammopharmacology       Date:  2018-03-22       Impact factor: 4.473

3.  Neuroprotective effect of L-deprenyl on the expression level of the Mst1 gene and inhibition of apoptosis in rat-model spinal cord injury.

Authors:  Alireza Abdanipour; Ali Nikfar; Mahsa Nikbakht Rad; Iraj Jafari Anarkooli; Mojdeh Mansouri
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

4.  Toxicogenomics of Phenylhydrazine Induced Hematotoxicity and its Attenuation by Plumbagin from Plumbago zeylanica.

Authors:  Pooja Shukla; R K Singh
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

5.  Natrium Benzoate Alleviates Neuronal Apoptosis via the DJ-1-Related Anti-oxidative Stress Pathway Involving Akt Phosphorylation in a Rat Model of Traumatic Spinal Cord Injury.

Authors:  Liansheng Gao; Zhongyuan Zhang; Weilin Xu; Tao Li; Guangyu Ying; Bing Qin; Jianru Li; Jingwei Zheng; Tengfei Zhao; Feng Yan; Yongjian Zhu; Gao Chen
Journal:  Front Mol Neurosci       Date:  2019-02-22       Impact factor: 5.639

Review 6.  Inflammation: A Target for Treatment in Spinal Cord Injury.

Authors:  Ximena Freyermuth-Trujillo; Julia J Segura-Uribe; Hermelinda Salgado-Ceballos; Carlos E Orozco-Barrios; Angélica Coyoy-Salgado
Journal:  Cells       Date:  2022-08-29       Impact factor: 7.666

7.  Imatinib inhibits oxidative stress response in spinal cord injury rats by activating Nrf2/HO-1 signaling pathway.

Authors:  Limin Liu; Jingyuan Zhou; Yufeng Wang; Tengmin Qi; Zengshun Wang; Linxu Chen; Nananxiu Suo
Journal:  Exp Ther Med       Date:  2019-12-02       Impact factor: 2.447

8.  Valproic Acid Ameliorates Locomotor Function in the Rat Model of Contusion via Alteration of Mst1, Bcl-2, and Nrf2 Gene Expression.

Authors:  Ali Mardi; Alireza Biglar; Reza Nejatbakhsh; Alireza Abdanipour
Journal:  Iran Biomed J       Date:  2021-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.